BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9484309)

  • 1. Determinants of the treatment climate in psychiatric and substance abuse programs: implications for improving patient outcomes.
    Timko C; Moos RH
    J Nerv Ment Dis; 1998 Feb; 186(2):96-103. PubMed ID: 9484309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community residential program policies, services, and treatment orientations influence patients' participation in treatment.
    Moos RH; King MJ; Burnett EB; Andrassy JM
    J Subst Abuse; 1997; 9():171-87. PubMed ID: 9494948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of the treatment climate in psychiatric and substance abuse programs.
    Timko C; Moos RH
    J Clin Psychol; 1998 Dec; 54(8):1137-50. PubMed ID: 9840784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders.
    Moos RH; Moos BS; Andrassy JM
    Psychiatr Serv; 1999 Dec; 50(12):1577-83. PubMed ID: 10577876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demand characteristics of residential substance abuse treatment programs.
    Timko C; Yu K; Moos RH
    J Subst Abuse; 2000; 12(4):387-403. PubMed ID: 11452841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in acute mental health care: comparing psychiatric and substance abuse treatment programs.
    Timko C; Lesar M; Calvi NJ; Moos RH
    J Behav Health Serv Res; 2003; 30(2):145-60. PubMed ID: 12710369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical characteristics of residential psychiatric and substance abuse programs: organizational determinants and patients outcomes.
    Timko C
    Am J Community Psychol; 1996 Feb; 24(1):173-92. PubMed ID: 8712185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Training substance abuse treatment staff to care for co-occurring disorders.
    Hunter SB; Watkins KE; Wenzel S; Gilmore J; Sheehe J; Griffin B
    J Subst Abuse Treat; 2005 Apr; 28(3):239-45. PubMed ID: 15857724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policies and services in residential substance abuse programs: comparisons with psychiatric programs.
    Timko C
    J Subst Abuse; 1995; 7(1):43-59. PubMed ID: 7655311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
    Lambert-Harris C; Saunders EC; McGovern MP; Xie H
    J Addict Med; 2013; 7(1):25-32. PubMed ID: 23188042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Program variation in treatment outcomes among women in residential drug treatment.
    Grella CE; Joshi V; Hser YI
    Eval Rev; 2000 Aug; 24(4):364-83. PubMed ID: 11009864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of substance abuse in severely mentally ill patients.
    Drake RE; Bartels SJ; Teague GB; Noordsy DL; Clark RE
    J Nerv Ment Dis; 1993 Oct; 181(10):606-11. PubMed ID: 8105026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of case management in the publicly funded substance abuse treatment system. The perspective of program directors, case managers and clients.
    Shwartz M; Stone DA; Camp J; Mulvey KP; Kane M; Plough A
    Care Manag J; 2000; 2(3):139-47. PubMed ID: 11398569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of 4-year outcome of community residential treatment for patients with substance use disorders.
    Laffaye C; McKellar JD; Ilgen MA; Moos RH
    Addiction; 2008 Apr; 103(4):671-80. PubMed ID: 18339113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on adolescent residential substance abuse treatment: when are adolescents done?
    Wisdom JP; Gogel LP
    Psychiatr Serv; 2010 Aug; 61(8):817-21. PubMed ID: 20675841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms and mentally ill chemical abusers' perception of the treatment environment in residential settings.
    Nuttbrock LA; Rahav MR; Rivera JJ; Ng-Mak DS
    Addict Behav; 1999; 24(1):139-44. PubMed ID: 10189982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.